Medacta Group SA (MEDGF)
83.91
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Medacta Group Total Assets (Quarterly): 769.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 769.22M |
| June 30, 2023 | 700.54M |
| June 30, 2023 | 700.54M |
| December 31, 2022 | 626.80M |
| June 30, 2022 | 575.40M |
| June 30, 2022 | 575.40M |
| December 31, 2021 | 553.96M |
| June 30, 2021 | 544.62M |
| Date | Value |
|---|---|
| June 30, 2021 | 544.62M |
| December 31, 2020 | 543.56M |
| June 30, 2020 | 481.08M |
| June 30, 2020 | 481.08M |
| December 31, 2019 | 462.14M |
| June 30, 2019 | 446.71M |
| June 30, 2019 | 446.71M |
| December 31, 2018 | 418.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
446.71M
Minimum
Jun 2019
769.22M
Maximum
Dec 2023
563.49M
Average
544.62M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| AC Immune SA | 217.65M |
| CRISPR Therapeutics AG | 2.230B |
| Addex Therapeutics Ltd | 5.526M |
| NLS Pharmaceutics Ltd | 2.270M |
| Molecular Partners AG | 236.15M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 404.39M |
| Shareholders Equity (Quarterly) | 364.82M |
| Debt to Equity Ratio | 0.4885 |
| Current Ratio | 2.332 |
| Net Debt Paydown Yield | -3.55% |